Advertisement
Screener

Cogent Biosciences, Inc. (COGT) Increase (Decrease) in Other Operating Assets

2.8 / 5 stars · 68/120 Roast Me

Cogent Biosciences, Inc. Increase (Decrease) in Other Operating Assets

Cogent Biosciences, Inc. (COGT) reported Increase (Decrease) in Other Operating Assets of -$1.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-10

  • Cogent Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$1.00K.
  • Cogent Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$1.36M.
  • Cogent Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$1.19M.
  • Cogent Biosciences, Inc. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$374.00K.
  • Cogent Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2025 was -$1.56M.
  • Cogent Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2024 was -$2.00K, a 101.68% decline from fiscal 2023.
  • Cogent Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2023 was $119.00K, a 88.31% decline from fiscal 2022.
  • Cogent Biosciences, Inc. increase (decrease) in other operating assets for fiscal 2022 was $1.02M, a 72.69% decline from fiscal 2021.
Period endIncrease (Decrease) in Other Operating Assets 3 monthIncrease (Decrease) in Other Operating Assets 6 monthIncrease (Decrease) in Other Operating Assets 9 monthIncrease (Decrease) in Other Operating Assets 12 month
2026-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$1.36M
10-Q · filed 2026-08-10
-$2.55M
derived: sum of 3 quarters · filed 2026-08-10
-$2.92M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$1.36M
10-Q · filed 2026-05-05
-$2.55M
derived: sum of 2 quarters · filed 2026-05-05
-$2.92M
derived: sum of 3 quarters · filed 2026-05-05
-$2.92M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
-$1.56M
derived: sum of 2 quarters · filed 2026-02-17
-$1.56M
derived: sum of 3 quarters · filed 2026-08-10
-$1.56M
10-K · filed 2026-02-17
2025-09-30-$374.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$374.00K
derived: sum of 2 quarters · filed 2026-08-10
-$374.00K
10-Q · filed 2025-11-07
-$378.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
$0.00
10-Q · filed 2026-08-10
-$4.00K
derived: sum of 3 quarters · filed 2026-08-10
-$4.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31$0.00
10-Q · filed 2026-05-05
-$4.00K
derived: sum of 2 quarters · filed 2026-05-05
-$4.00K
derived: sum of 3 quarters · filed 2026-05-05
-$4.00K
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31-$4.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
-$4.00K
derived: sum of 2 quarters · filed 2026-02-17
-$4.00K
derived: sum of 3 quarters · filed 2026-02-17
-$2.00K
10-K · filed 2026-02-17
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2025-11-07
$2.00K
10-Q · filed 2025-11-07
$4.00K
derived: sum of 4 quarters · filed 2026-02-17
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$2.00K
10-Q · filed 2025-08-05
$4.00K
derived: sum of 3 quarters · filed 2026-02-17
$91.00K
derived: sum of 4 quarters · filed 2026-02-17
2024-03-31$2.00K
10-Q · filed 2025-05-06
$4.00K
derived: sum of 2 quarters · filed 2026-02-17
$91.00K
derived: sum of 3 quarters · filed 2026-02-17
$91.00K
derived: sum of 4 quarters · filed 2026-02-17
2023-12-31$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$89.00K
derived: sum of 2 quarters · filed 2026-02-17
$89.00K
derived: sum of 3 quarters · filed 2026-02-17
$119.00K
10-K · filed 2026-02-17
2023-09-30$87.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$87.00K
derived: sum of 2 quarters · filed 2024-11-12
$117.00K
10-Q · filed 2024-11-12
$94.00K
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$30.00K
10-Q · filed 2024-08-06
$7.00K
derived: sum of 3 quarters · filed 2025-02-25
-$120.00K
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$30.00K
10-Q · filed 2024-05-07
$7.00K
derived: sum of 2 quarters · filed 2025-02-25
-$120.00K
derived: sum of 3 quarters · filed 2025-02-25
-$831.00K
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31-$23.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$150.00K
derived: sum of 2 quarters · filed 2025-02-25
-$861.00K
derived: sum of 3 quarters · filed 2025-02-25
$1.02M
10-K · filed 2025-02-25
2022-09-30-$127.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$838.00K
derived: sum of 2 quarters · filed 2023-11-07
$1.04M
10-Q · filed 2023-11-07
$2.73M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30-$711.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$1.17M
10-Q · filed 2023-08-08
$2.86M
derived: sum of 3 quarters · filed 2024-02-26
$2.92M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31$1.88M
10-Q · filed 2023-05-09
$3.57M
derived: sum of 2 quarters · filed 2024-02-26
$3.64M
derived: sum of 3 quarters · filed 2024-02-26
2021-12-31$1.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
$1.76M
derived: sum of 2 quarters · filed 2024-02-26
$3.73M
10-K · filed 2024-02-26
2021-09-30$66.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$2.04M
10-Q · filed 2022-11-14
2021-06-30$1.97M
10-Q · filed 2022-08-09
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$0.00
derived: sum of 2 quarters · filed 2022-03-15
$0.00
derived: sum of 3 quarters · filed 2022-03-15
-$427.00K
10-K · filed 2022-03-15
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
$0.00
derived: sum of 2 quarters · filed 2021-11-10
-$427.00K
10-Q · filed 2021-11-10
-$428.00K
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
-$427.00K
10-Q · filed 2021-08-16
-$428.00K
derived: sum of 3 quarters · filed 2021-08-16
-$427.00K
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$427.00K
10-Q · filed 2021-05-12
-$428.00K
derived: sum of 2 quarters · filed 2021-05-12
-$427.00K
derived: sum of 3 quarters · filed 2021-05-12
-$427.00K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31-$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$0.00
derived: sum of 2 quarters · filed 2021-03-16
$0.00
derived: sum of 3 quarters · filed 2021-03-16
$427.00K
10-K · filed 2021-03-16
2019-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$1.00K
derived: sum of 2 quarters · filed 2020-11-09
$428.00K
10-Q · filed 2020-11-09
$428.00K
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11
$427.00K
10-Q · filed 2020-08-11
$427.00K
derived: sum of 3 quarters · filed 2020-08-11
$427.00K
derived: sum of 4 quarters · filed 2020-08-11
2019-03-31$427.00K
10-Q · filed 2020-05-11
$427.00K
derived: sum of 2 quarters · filed 2020-05-11
$427.00K
derived: sum of 3 quarters · filed 2020-05-11
$427.00K
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26
$0.00
derived: sum of 2 quarters · filed 2020-03-26
$0.00
derived: sum of 3 quarters · filed 2020-03-26
$419.00K
10-K · filed 2020-03-26
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$0.00
derived: sum of 2 quarters · filed 2019-11-12
$419.00K
10-Q · filed 2019-11-12
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
$419.00K
10-Q · filed 2019-08-12
2018-03-31$419.00K
10-Q · filed 2019-05-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Veradermics, Inc (MANE)United States$4.839B
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Liquidia Corp (LQDA)United States$6.347B51.23